X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3000) 3000
Book Review (977) 977
Publication (159) 159
Newsletter (57) 57
Conference Proceeding (30) 30
Magazine Article (30) 30
Book Chapter (17) 17
Trade Publication Article (11) 11
Newspaper Article (10) 10
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2090) 2090
humans (1964) 1964
dabigatran (1919) 1919
dabigatran etexilate (1497) 1497
warfarin (1219) 1219
anticoagulants (1173) 1173
rivaroxaban (1064) 1064
atrial fibrillation (971) 971
anticoagulants - therapeutic use (778) 778
administration, oral (705) 705
male (701) 701
venous thromboembolism (676) 676
stroke (660) 660
apixaban (648) 648
female (641) 641
anticoagulants - administration & dosage (603) 603
prevention (600) 600
anticoagulants - adverse effects (594) 594
aged (581) 581
atrial fibrillation - drug therapy (570) 570
hematology (561) 561
atrial-fibrillation (553) 553
peripheral vascular disease (516) 516
beta-alanine - analogs & derivatives (511) 511
pharmacology & pharmacy (500) 500
direct thrombin inhibitor (489) 489
stroke - prevention & control (482) 482
cardiac & cardiovascular systems (472) 472
hemorrhage - chemically induced (448) 448
risk factors (447) 447
thrombin (428) 428
benzimidazoles - therapeutic use (419) 419
thromboembolism (409) 409
middle aged (397) 397
atrial fibrillation - complications (387) 387
benzimidazoles - adverse effects (368) 368
treatment outcome (364) 364
drug therapy (355) 355
anticoagulation (331) 331
benzimidazoles - administration & dosage (323) 323
medicine & public health (310) 310
etexilate (304) 304
stroke prevention (304) 304
medicine, general & internal (302) 302
pharmacokinetics (296) 296
dosage and administration (295) 295
aged, 80 and over (294) 294
care and treatment (290) 290
abridged index medicus (287) 287
oral anticoagulants (286) 286
analysis (283) 283
double-blind (283) 283
enoxaparin (283) 283
antithrombins - adverse effects (272) 272
warfarin - therapeutic use (272) 272
management (269) 269
blood coagulation - drug effects (267) 267
safety (266) 266
antithrombins - therapeutic use (255) 255
stroke - etiology (250) 250
cardiac arrhythmia (247) 247
venous thromboembolism - prevention & control (243) 243
bleeding (239) 239
therapy (239) 239
pyridines - therapeutic use (238) 238
thrombosis (235) 235
hemorrhage (231) 231
beta-alanine - adverse effects (230) 230
cardiology (229) 229
beta-alanine - therapeutic use (225) 225
surgery (221) 221
pharmacodynamics (219) 219
animals (218) 218
factor-xa inhibitor (218) 218
risk (218) 218
factor xa inhibitors (212) 212
research (212) 212
anticoagulants - pharmacology (208) 208
deep-vein thrombosis (208) 208
factor xa inhibitor (208) 208
antithrombins - administration & dosage (207) 207
warfarin - adverse effects (196) 196
edoxaban (192) 192
thromboprophylaxis (191) 191
health aspects (189) 189
internal medicine (188) 188
beta-alanine - administration & dosage (186) 186
dabigatran - therapeutic use (186) 186
vitamin k - antagonists & inhibitors (186) 186
dabigatran - adverse effects (182) 182
usage (182) 182
antithrombotic therapy (179) 179
thromboembolism - prevention & control (178) 178
complications and side effects (176) 176
adult (174) 174
pyrazoles - therapeutic use (170) 170
pyridones - therapeutic use (170) 170
anticoagulants - pharmacokinetics (168) 168
reversal (168) 168
pyridines - administration & dosage (167) 167
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2855) 2855
German (65) 65
Spanish (64) 64
French (60) 60
Russian (29) 29
Japanese (11) 11
Czech (10) 10
Italian (8) 8
Portuguese (5) 5
Chinese (2) 2
Danish (2) 2
Hungarian (2) 2
Polish (2) 2
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Drugs, ISSN 0012-6667, 2008, Volume 68, Issue 12, pp. 1699 - 1709
▴ Dabigatran etexilate is an orally administered prodrug of dabigatran, which is a potent, concentration-dependent inhibitor of thrombus formation and... 
Dabigatran etexilate | Thromboembolism | Research and development | Adis Drug Profiles | Orthopaedic surgery | Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Dabigatran etexilate, general | Thromboembolism, prevention | IN-VITRO | DIRECT THROMBIN INHIBITOR | ORTHOPEDIC-SURGERY | KNEE REPLACEMENT | VENOUS THROMBOEMBOLISM | PHARMACOKINETICS | PREVENTION | TOTAL HIP-REPLACEMENT | RANDOMIZED-TRIAL | PHARMACOLOGY & PHARMACY | PHARMACODYNAMICS | TOXICOLOGY | Area Under Curve | Pyridines - chemistry | Humans | Half-Life | Pyridines - pharmacokinetics | Dabigatran | Benzimidazoles - chemistry | Suppuration - chemically induced | Surgical Wound Infection - chemically induced | Molecular Structure | Platelet Aggregation - drug effects | Thromboembolism - drug therapy | Thrombosis - prevention & control | Benzimidazoles - therapeutic use | Pyridines - therapeutic use | Prodrugs | Anemia - chemically induced | Benzimidazoles - pharmacokinetics | Anticoagulants - therapeutic use | Treatment Outcome | Anticoagulants - adverse effects | Randomized Controlled Trials as Topic | Anticoagulants - pharmacokinetics | Thrombosis - drug therapy | Hemorrhage - chemically induced | Complications and side effects | Dosage and administration | Venous thrombosis | Drug therapy | Patient outcomes | Index Medicus
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 01/2009, Volume 101, Issue 1, pp. 77 - 85
Dabigatran etexilate has been investigated in three phase III trials for the prevention of venous thromboembolism (VTE). Health technology assessment agencies... 
anticoagulants | thrombosis | prophylaxis | Embolism | Meta-analysis | Anticoagulants | Thrombosis | Prophylaxis | ENOXAPARIN | meta-analysis | RANDOMIZED-TRIAL | REPLACEMENT | ORTHOPEDIC-SURGERY | MOLECULAR-WEIGHT HEPARIN | THROMBOSIS PROPHYLAXIS | US HOSPITALS | PERIPHERAL VASCULAR DISEASE | THROMBOPROPHYLAXIS | HEMATOLOGY | UNFRACTIONATED HEPARIN | REGISTRY | Venous Thromboembolism - mortality | Anticoagulants - administration & dosage | Arthroplasty, Replacement, Knee - adverse effects | Humans | Dabigatran | Enoxaparin - therapeutic use | Enoxaparin - adverse effects | Venous Thromboembolism - prevention & control | Clinical Trials, Phase III as Topic | Enoxaparin - administration & dosage | Pyridines - adverse effects | Benzimidazoles - administration & dosage | Benzimidazoles - adverse effects | Benzimidazoles - therapeutic use | Pyridines - therapeutic use | Pyridines - administration & dosage | Drug Administration Schedule | Risk Assessment | Administration, Oral | Anticoagulants - therapeutic use | Treatment Outcome | Anticoagulants - adverse effects | Arthroplasty, Replacement, Hip - adverse effects | Venous Thromboembolism - etiology | Hemorrhage - chemically induced | Index Medicus | Administration | Phase III as Topic | Benzimidazoles/administration & dosage/adverse effects/therapeutic use | Pyridines/administration & dosage/adverse effects/therapeutic use | Arthroplasty | Replacement | Oral | Clinical Trials | Kirurgi | Knee/adverse effects | Hemorrhage/chemically induced | Venous Thromboembolism/etiology/mortality/prevention & control | Hip/adverse effects | Anticoagulants/administration & dosage/adverse effects/therapeutic use | Surgery | Enoxaparin/administration & dosage/adverse effects/therapeutic use
Journal Article
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 04/2013, Volume 75, Issue 4, pp. 1053 - 1062
Journal Article
American Heart Journal, ISSN 0002-8703, 2012, Volume 163, Issue 6, pp. 931 - 937.e1
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 05/2012, Volume 107, Issue 5, pp. 985 - 997
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 09/2016, Volume 116, Issue 3, pp. 461 - 471
Venous thromboembolism (VTE) incidence is increasing among children owing to many factors, including improved diagnosis of VIE. There is a need for alternative... 
Direct thrombin inhibitors | Anticoagulants | Dabigatran | Venous thromboembolism | Adolescent | POPULATION | RE-LY TRIAL | THROMBOSIS | MATURATION | CHILDHOOD | ATRIAL-FIBRILLATION | CHILDREN | WARFARIN | venous thromboembolism | PEDIATRIC-PATIENTS | anticoagulants | dabigatran | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | direct thrombin inhibitors
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 06/2013, Volume 61, Issue 22, pp. 2264 - 2273
Journal Article
Journal Article
Journal of thrombosis and haemostasis, ISSN 1538-7933, 2007, Volume 5, Issue 11, pp. 2178 - 2185
Journal Article
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 11/2011, Volume 9, Issue 11, pp. 2168 - 2175
Journal Article